evolving with purpose: janssen’s new identity within johnson & johnson
Published 9 months ago • 133 plays • Length 0:17Download video MP4
Download video MP3
Similar videos
-
1:54
introducing janssen in urology
-
1:18
in front of cancer: advancing multiple myeloma treatment
-
4:23
in front of cancer: advancing multiple myeloma treatment – from research to reality
-
1:15
janssen’s history of doing more for infectious diseases & vaccines
-
2:19
the janssen pharmaceutical companies of johnson & johnson
-
3:15
janssen’s advac® technology
-
5:48
overview of dna damage
-
1:36
cancer interception unlocked
-
1:16
in front of cancer
-
1:40
in front of cancer: charles’ story
-
0:35
juan ortega - vantage orian 1.5t encore upgrade - trusted partnership
-
1:31:29
the innovation and r&d podium - janssen research and development
-
2:15
dna damage repair pathways and wee1 as possible therapeutic targets in sclc
-
0:31
cancer interception unlocked - episode 1
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
2:39:36
april 14, 2021 acip meeting - welcome & coronavirus disease 2019 (covid-19) vaccines
-
1:38
program update | new genome center partners
-
3:48
not all gene changes are the same: variants of unknown clinical significance
-
1:58
can wgs and rnaseq replace conventional first-line diagnostics for acute leukemia?
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
19:09
breast cancer predisposition genes and beyond: role in prevention and treatment
-
1:37:42
a closer look at...covid-19